EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation

Leon J Wils iD, Marijke Buijze, Marijke Stigter-van Walsum iD, Arjen Brink, Britt E van Kempen, Laura Peferoen iD, Elisabeth R Brouns, Jan G A M de Visscher iD, Erik H van der Meij, Elisabeth Bloemena iD, Jos B Poell iD, Ruud H Brakenhoff

Cells · 2024

DOI: 10.3390/cells13080710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Leon J Wils und 11 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC Location Vrije Universiteit Amsterdam, Oral and Maxillofacial Surgery and Oral Pathology, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Keratinocytes, Mouth Neoplasms, Leukoplakia, Oral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hanarth Fonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precancerous cells in the oral cavity may appear as oral potentially malignant disorders, but they may also present as dysplasia without visual manifestation in tumor-adjacent tissue. As it is currently not possible to prevent the malignant transformation of these oral precancers, new treatments are urgently awaited. Here, we generated precancer culture models using a previously established method for the generation of oral keratinocyte cultures and incorporated CRISPR/Cas9 editing. The generated cell lines were used to investigate the efficacy of a set of small molecule inhibitors. Tumor-adjacent mucosa and oral leukoplakia biopsies were cultured and genetically characterized. Mutations were introduced in CDKN2A and TP53 using CRISPR/Cas9 and combined with the ectopic activation of telomerase to generate cell lines with prolonged proliferation. The method was tested in normal oral keratinocytes and tumor-adjacent biopsies and subsequently applied to a large set of oral leukoplakia biopsies. Finally, a subset of the immortalized cell lines was used to assess the efficacy of a set of small molecule inhibitors. Culturing and genomic engineering was highly efficient for normal and tumor-adjacent oral keratinocytes, but success rates in oral leukoplakia were remarkably low. Knock-out of CDKN2A in combination with either the activation of telomerase or knock-out of TP53 seemed a prerequisite for immortalization. Prolonged culturing was accompanied by additional genetic aberrations in these cultures. The generated cell lines were more sensitive than normal keratinocytes to small molecule inhibitors of previously identified targets. In conclusion, while very effective for normal keratinocytes and tumor-adjacent biopsies, the success rate of oral leukoplakia cell culturing methods was very low. Genomic engineering enabled the prolonged culturing of OL-derived keratinocytes but was associated with acquired genetic changes. Further studies are required to assess to what extent the immortalized cultures faithfully represent characteristics of the cells in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratinocytesMouth NeoplasmsLeukoplakia, OralHumansTelomeraseGenetic EngineeringCyclin-Dependent Kinase Inhibitor p16CRISPR-Cas SystemsTumor Suppressor Protein p53Mouth MucosaPrecancerous Conditions

Stichwörter der Autor:innen

CRISPR/Cas9cell culture modelsgenetic engineeringmalignant transformationoral diseasesoral leukoplakiaoral squamous cell carcinomasmall molecule inhibitors

Substanzen

TelomeraseCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Amsterdam UMC Location Vrije Universiteit Amsterdam, Oral and Maxillofacial Surgery and Oral Pathology, 1081 HV Amsterdam, The Netherlands.
  • Amsterdam UMC Location Vrije Universiteit Amsterdam, Otolaryngology and Head & Neck Surgery, 1081 HV Amsterdam, The Netherlands.
  • Amsterdam UMC Location Vrije Universiteit Amsterdam, Pathology, 1081 HV Amsterdam, The Netherlands.
  • Academic Centre for Dentistry Amsterdam (ACTA), 1081 LA Amsterdam, The Netherlands.
  • Cancer Center Amsterdam (CCA), Cancer Biology and Immunology, 1081 HV Amsterdam, The Netherlands.

ORCID-Profile: Leon J Wils, Marijke Stigter-van Walsum, Laura Peferoen, Jan G A M de Visscher, Elisabeth Bloemena, Jos B Poell

Förderung

  • Hanarth Fonds

Zitieren

APA

Wils, L. J., Buijze, M., Stigter-van Walsum, M., Brink, A., van Kempen, B. E., Peferoen, L., Brouns, E. R., de Visscher, J. G. A. M., van der Meij, E. H., Bloemena, E., Poell, J. B., & Brakenhoff, R. H. (2024). Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells. https://doi.org/10.3390/cells13080710

Vancouver

Wils LJ, Buijze M, Stigter-van Walsum M, Brink A, van Kempen BE, Peferoen L, et al. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation. Cells. 2024. doi:10.3390/cells13080710

BibTeX
@article{Wils2024,
  author = {Wils, Leon J and Buijze, Marijke and Stigter-van Walsum, Marijke and Brink, Arjen and van Kempen, Britt E and Peferoen, Laura and Brouns, Elisabeth R and de Visscher, Jan G A M and van der Meij, Erik H and Bloemena, Elisabeth and Poell, Jos B and Brakenhoff, Ruud H},
  title = {Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13080710}
}
Kostenlos starten →